The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes
Open accessAbstract
Nowadays, obesity is seriously increasing in most of the populations all over the world, and is associated with the development and progression of high-mortality diseases such as type-2 diabetes mellitus (T2DM) and its subsequent cardiovascular pathologies. Recent data suggest that both body fat distribution and adipocyte phenotype, can be more determinant for fatal outcomes in obese patients than increased general adiposity. In particular, visceral adiposity is significantly linked to long term alterations on different cardiac structures, and in developed forms of myocardial diseases such as hypertensive and ischaemic heart diseases, and diabetic cardiomyopathy. Interestingly, this depot may be also related to epicardial fat accumulation through secretion of lipids, adipokines, and pro-inflammatory and oxidative factors from adipocytes. Thus, visceral adiposity and its white single-lipid-like adipocytes, are risk factors for different forms of heart disease and heart failure, mainly in higher degree obese subjects. However, under specific stimuli, some of these adipocytes can transdifferentiate to brown multi-mitochondrial-like adipocytes with anti-inflammatory and anti-apoptotic proprieties. Accordingly, in order to improve potential cardiovascular abnormalities in obese and T2DM patients, several therapeutic strategies have been addressed to modulate the visceral and epicardial fat volume and phenotypes. In addition to lifestyle modifications, specific genetic manipulations in adipose tissue and administration of PPARγ agonists or statins, have improved fat volume and phenotype, and cardiovascular failures. Furthermore, incretin stimulation reduced visceral and epicardial fat thickness whereas increased formation of brown adipocytes, alleviating insulin resistance and associated cardiovascular pathologies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“More specifically, treatments ameliorating the altered composition and distribution of fat stores may produce the best results [117].”
From Dysregulated epicardial adipose tissue as a risk factor and potential therapeutic target of heart failure with preserved ejection fraction in diabetes (2022) · cites this paper as [117]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Child abuse: Adolescent records vs. adult recall
Femina, D. D., Yeager, C. A., & Lewis, D. O. (1990) · Child Abuse & Neglect · doi:10.1016/0145-2134(90)90033-p · Cited by 8,820
Brown Adipose Tissue: Function and Physiological Significance
CANNON, B., & NEDERGAARD, J. (2004) · Physiological Reviews · doi:10.1152/physrev.00015.2003 · Cited by 6,433
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,720
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
Fox, C. S., Massaro, J. M., Hoffmann, U., Pou, K. M., Maurovich-Horvat, P., Liu, C.-Y., Vasan, R. S., Murabito, J. M., Meigs, J. B., Cupples, L. A., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.675355 · Cited by 2,882 · cited 1×
“However, excessive VAT was more pathogenic than overloaded subcutaneous fat, since VAT closely linked to cardiometabolic abnormalities [12].”
BackgroundExcess Deaths Associated With Underweight, Overweight, and Obesity
Flegal, K. M. (2005) · JAMA · doi:10.1001/jama.293.15.1861 · Cited by 2,811
Pathophysiology of human visceral obesity: an update
Tchernof, A., & Després, J.-P. (2013) · Physiological Reviews · doi:10.1152/physrev.00033.2011 · Cited by 2,583 · cited 1×
“The main etiological factors include age, gender, sex and growth hormones, the endocannabinoid and hypothalamus–pituitary–adrenal systems, glucocorticoids, nutritional factors, and physical activity [23].”
BackgroundPrdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice
Seale, P., Conroe, H. M., Estall, J. L., Kajimura, S., Frontini, A., Ishibashi, J., Cohen, P., Cinti, S., & Spiegelman, B. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci44271 · Cited by 1,273 · cited 1×
“Transgenic overexpression of PRDM-16 in subcutaneous WAT protected mice from diet-induced obesity and insulin resistance [84].”
BackgroundWang, Y., Rimm, E. B., Stampfer, M. J., Willett, W. C., & Hu, F. B. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.3.555 · Cited by 1,130 · cited 1×
“In this sense, VAT accumulation has been correlated with increasing incidence of T2DM, T2DM-associated chronic low-grade inflammation, atherogenic dyslipidemia, and hypertension [13, 14].”
BackgroundThe effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes
Gaich, G., Chien, J. Y., Fu, H., Glass, L. C., Deeg, M. A., Holland, W. L., Kharitonenkov, A., Bumol, T., Schilske, H. K., & Moller, D. E. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.005 · Cited by 885 · cited 1×
“Also, administration of FGF21 in humans improved hyperlipidemia by lowering plasma TAG and LDL-C levels, while increasing HDL-C levels [61].”
Background
Research works printed but not linked: 1
- Quintero-Castillo D, Luz-Araujo H, Guerra-Velázquez M, Reyna-Villasmil E, Santos Bolívar J, Torres-Cepeda D, et al. Lipid profile in obese and non-obese women with polycystic ovary syndrome treated with metformin. Endocrinol Nutr Organo Soc Espanola Endocrinol Nutr. 2010;57:262–7.
Cited by
Sorted by citations
Items 101–200 of 210
Obesity and Transcatheter Aortic Valve Replacement
Seo, J., Kharawala, A., Borkowski, P., Singh, N., Akunor, H., Nagraj, S., Avgerinos, D. V., & Kokkinidis, D. G. (2024) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd11060169 · Cited by 8
BMPER is upregulated in obesity and seems to have a role in pericardial adipose stem cells
Pérez, L. M., de Lucas, B., & Gálvez, B. G. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29829 · Cited by 8
Katsiki, N., & Mikhailidis, D. P. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29573 · Cited by 8
Yu, S.-Y. (2022) · World Journal of Emergency Medicine · doi:10.5847/wjem.j.1920-8642.2022.072 · Cited by 8
Loss of transketolase promotes the anti-diabetic role of brown adipose tissues
Ji, Y., Liu, W., Zhu, Y., Li, Y., Lu, Y., Liu, Q., Tong, L., Hu, L., Xu, N., Chen, Z., et al. (2022) · Journal of Endocrinology · doi:10.1530/joe-22-0047 · Cited by 7
Evans, A. J., & Li, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212464 · Cited by 8
“Under pathological conditions, such as T2DM, EAT-secreted adipokines can induce inflammatory cascades (discussed below), and EAT-released excessive FFAs can induce lipotoxicity, when adipokines/FFAs are taken up by neurons [195–198].”
Autoimmune reaction against pancreatic beta cells in children and adolescents with simple obesity
Chylińska-Frątczak, A., Pietrzak, I., Michalak, A., Wyka, K., & Szadkowska, A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1061671 · Cited by 7
Baig, M., Gazzaz, Z. J., Bakarman, M. A., & Alzahrani, S. H. (2021) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.37.7.4330 · Cited by 7
Hogea, T., Noemi, N., Suciu, B. A., Brînzaniuc, K., Chinezu, L., Arbănași, E. M., Kaller, R., Carașcă, C., Arbănași, E. M., Vunvulea, V., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13132157 · Cited by 7
Interplay between epicardial adipose tissue, metabolic and cardiovascular diseases
Bornachea, O., Vea, À., & Llorente‐Cortés, V. (2018) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2018.09.001 · Cited by 7
Melin, E. O., Hillman, M., Thunander, M., & Landin‐Olsson, M. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0481-3 · Cited by 9
Hu, X., Jia, F., Li, X., Chen, W., Zhang, L., Pan, J., Zhu, S., Wang, Z., & Huang, J. (2025) · Translational Oncology · doi:10.1016/j.tranon.2025.102408 · Cited by 6
Jiao, M., Chen, J., Wang, X., Tao, W., Feng, Y., Yang, H.-J., Yang, H., Zhao, S., Yang, Y., & Li, Y. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01583-1 · Cited by 6
The cardiometabolic benefits of exercise in postmenopausal women
Chrysant, S. G. (2020) · Journal of Clinical Hypertension · doi:10.1111/jch.13968 · Cited by 6
Korkut, M., Selvi, F., & Bedel, C. (2022) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2021.0461.r1.16082021 · Cited by 6
Visceral fat and its dynamic change are associated with renal damage: Evidence from two cohorts
Lin, M., Wu, S., Deng, X., Chen, Y., & Tan, X. (2023) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2023.2271187 · Cited by 6
“Recently, visceral adiposity has become the focus of research because it has been shown to be more closely related to target organ injury (9,10).”
BackgroundShahawy, M. E., Tucker, S., Izadi, L., Sabatini, A., & Mohan, S. (2021) · The Egyptian Heart Journal · doi:10.1186/s43044-021-00159-4 · Cited by 6
“Additionally, other studies have found an association between excess EFV and metabolic syndrome [7, 8].”
BackgroundLyngbakken, M. N., de Lemos, J. A., Hveem, K., Røsjø, H. R., & Omland, T. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13391 · Cited by 7
“Visceral fat deposits correlate with epicardial fat, which in turn cause abnormalities in cardiac function and structure, leading to left ventricular hypertrophy, diastolic dysfunction, and ultimately overt heart failure [30].”
BackgroundMiya, A., Nakamura, A., Suzuki, Y., Nomoto, H., Kameda, H., Cho, K. Y., Ito, Y. M., Nagai, S., Miyoshi, H., & Atsumi, T. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15049 · Cited by 5
“Studies have shown that visceral adipocytes secrete cytokines, known as adipokines, which contribute to pathologies of metabolic systems.(10,11) Among them, adiponectin is one of the beneficial adipokines that enhances insulin sensitivity.”
BackgroundSingle-Cell Landscape and a Macrophage Subset Enhancing Brown Adipocyte Function in Diabetes
Gu, J.-F., Jin, J.-J., Ren, X.-Y., Zhang, X., Li, J., Wang, X.-W., Zhang, S.-C., Yin, X.-L., Zhang, Q.-Y., & Wang, Z. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0278 · Cited by 4
“BAT is known to burn fat through thermogenesis and its dysfunction significantly contributes to the development of many metabolic diseases [45].”
Zhang, S.-J., Wang, S., Liu, S., Li, P., Huang, D.-L., Zeng, X.-X., Lan, T., Ruan, Y., Shi, H.-J., & Zhang, X. (2024) · Heart Failure Reviews · doi:10.1007/s10741-024-10478-8 · Cited by 5
“…receptor-γ agonists Pioglitazone and rosiglitazone [113] (the European Medicines Agency has withdrawn rosiglitazone due to safety concerns [114, 115] Statins Statins [116, 117], selegiline [ [124] lipase on cardiomyocytes that is essential for breaking down triglycerides [122, 127].”
Mondragón-García, A., Luna‐Luna, M., Flores‐Castillo, C., Aranda‐Fraustro, A., Carreón‐Torres, E., López‐Olmos, V., Fragoso, J. M., Vargas‐Alarcón, G., & Pérez-Méndez, O. A. (2019) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248419838517 · Cited by 5
Zhang, Y., Liu, S., Fan, C., Zeng, Y., Li, J., Xie, C., Xue, Y., & Guan, M. (2019) · Europe PMC (PubMed Central) · doi:10.12122/j.issn.1673-4254.2019.04.11 · Cited by 5
Cheang, I., Zhu, X., Lu, X., Shi, S., Yue, X., Tang, Y., Gao, Y., Liao, S., Yao, W., Zhou, Y., et al. (2024) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-024-03048-4 · Cited by 4
Myocardial function, mechanics and work by echocardiography in adolescents with severe obesity
Guillermo Larios, G., Uribe, S. A., Claudia Trincado, G., Arancibia-Galilea, F., Paulo Valderrama, E., Espejo, J. P., Amézquita, M. V., & Salesa Barja, Y. (2024) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000301 · Cited by 4
“First, it increases mechanical stress on both ventricles, resulting in an elevated cardiac workload and LV hypertrophy and aggravating the atrial enlargement and ventricular diastolic dysfunction because of reduced compliance [20 – 23].”
Delkash, P., Bayat, B., & Omidi, F. (2024) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.15272 · Cited by 4
Dittfeld, C., Bienger, K., Andres, J., Plötze, K., Jannasch, A., Waldow, T., Tugtekin, S., & Matschke, K. (2018) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-170341 · Cited by 4
“The fact that numerous factors are secreted by adipocytes has become scientific focus in the 1990s and adipose tissue has been reclassified as an endocrine organ [1, 3, 4].”
Promising areas of pharmacotherapy for obesity
Druzhilov, М. A., Kuznetsova, Т. Y., & Chumakova, G. A. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4279 · Cited by 4
Claussen, M., Friese, G., & Theis, S. (2022) · Aktuelle Ernährungsmedizin · doi:10.1055/a-1740-3572 · Cited by 4
“…für eine große Anzahl von Begleit-und Folgeerkrankungen [3] wie insbesondere Diabetes mellitus Typ 2 (DM 2) [4], Herz-Kreislauf-Erkrankungen [5, 6], Fettleber, sie reduziert die Lebensqualität [7], führt zu einigen Krebserkrankungen, z. B. Colon-oder Mammakarzinom [8] und er-höht mit 20–25…”
BackgroundCorrelation between epicardial fat thickness and biochemical markers of metabolic risk
Rubio-Guerra, A. F., Benítez-Maldonado, D. R., Lozano-Nuevo, J. J., Arana-Pazos, K. C., Huerta-Ramírez, S., & Narváez-Rivera, J. L. (2018) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2018.07.008 · Cited by 4
Huang, B., Chang, S., Yun, C., Sung, K., Lai, Y., Lo, C., Huang, W., Chien, S., Liu, L. Y., Hung, T., et al. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12761 · Cited by 3
“Except for dysglycaemic signalling, an alternative pathophysiological link between excessive VAT and myocardial damage has recently been proposed from high levels of circulating free fatty acids and dysregulated metabolic profiles [such as high-density lipoprotein (HDL) or triglyceride (TG)(4)] in mediating excessive…”
BackgroundInfluentialWang, Z., Jiao, S., Chen, J., Guo, H., Ren, L., Sun, L., Sun, Y., & Chen, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1219890 · Cited by 3
“In obese and T2D patients, the EAT is thickened and dysfunctional, promoting cardiovascular damage (22).”
BackgroundSánchez, I. M. B., Aristizábal‐Duque, C. H., Cabeza, J. F., Vaquero, M., Martínez, P. A., Abellán, M. V., Ortiz, M. R., Rubio, M. D. M., & del Pozo, F. J. F. (2024) · Nutrients · doi:10.3390/nu16193321 · Cited by 3
Correlación entre el grosor de la grasa epicárdica y los marcadores bioquímicos de riesgo metabólico
Rubio-Guerra, A. F., Benítez-Maldonado, D. R., Lozano-Nuevo, J. J., Arana-Pazos, K. C., Huerta-Ramírez, S., & Narváez-Rivera, J. L. (2018) · Medicina Clínica · doi:10.1016/j.medcli.2018.01.019 · Cited by 3
Epicardial Adipose Tissue in the Progression and Calcification of the Coronary Artery Disease
Luna‐Luna, M., Zentella‐Dehesa, A., & Pérez-Méndez, O. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-47336-5_11 · Cited by 3
Bioreactors and microphysiological systems for adipose-based pharmacologic screening
Griffin, M. D., & Abbott, R. D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819376-1.00011-1 · Cited by 3
Sukhatme, M. G., Kar, A., Arasu, U. T., Lee, S. H., Alvarez, M., Garske, K. M., Gelev, K. Z., Rajkumar, S., Das, S. S., Kamińska, D., et al. (2024) · medRxiv · doi:10.1101/2024.11.22.24317804 · Cited by 5
Bombaci, B., Passanisi, S., Torre, A., Sbilordo, S., Ini’, E., Papa, M., Valenzise, M., Lombardo, F., & Salzano, G. (2025) · Diabetology · doi:10.3390/diabetology6090090 · Cited by 6
Increasing the rigor of body composition and adiposity measurement in multiple sclerosis research
Taylor, M. G., Goss, A. M., & Wingo, B. C. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1737057 · Cited by 2
“DXA can also be used to estimate regional body composition including fat and lean tissue mass in the legs, trunk, gynoid and android regions, and ratios of waist-to-hip mass and trunk-to-limb mass may then be calculated, allowing for better estimation of central adiposity (30, 31).”
Association of Region‐Specific Cardiac Adiposity With Dysglycemia and New‐Onset Diabetes
Sung, K., Kuo, J., Yun, C., Lin, Y., Tsai, J., Lo, C., Hsiao, C., Lai, Y., Tsai, C., Hou, C. J., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.021921 · Cited by 2
“…vasculature) have been shown to be biologically active rather than passive fat stores, and have unique functional and anatomical characteristics, 29,30 adi-posopathy (“sick fat”) develops when adipose tissues cause functional abnormalities through endocrinological, metabolic, and immunological…”
A Correlational Study on Cardiopulmonary Endurance in Male Patients with New-Onset Type 2 Diabetes
Liu, B., Niu, Z.-R., Jia, X., Liu, X., & Lü, Q. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s352798 · Cited by 2
“Furthermore, visceral obesity has a long-term effect on the structure of the heart, leading to high plasma pressure, diabetic cardiomyopathy, etc.(11) Han et al(12) compared Table 1 Comparison of General Information, Abdominal Visceral Fat, Plasma Glucose, CPET, and Other Indicators”
BackgroundHip BMD is associated with visceral fat change: a registry study of osteoporosis and sarcopenia
Chen, Y., Wang, Y., Ko, C., Chen, J., Hsu, C., Yu, S., & Cheng, T. (2022) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223221134051 · Cited by 2
Quarta, S., Santarpino, G., Carluccio, M. A., Calabriso, N., Cardetta, F., Siracusa, L., Strano, T., Palamà, I. E., Leccese, G., Visioli, F., et al. (2024) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2024.08.006 · Cited by 2
Beta cell function as an assessment tool for cardiovascular risk in patients with metabolic syndrome
Erman, H., Böyük, B., Cetin, S. I., Sevinç, S., Bulut, Ü., & Maviş, O. (2021) · Journal of Surgery and Medicine · doi:10.28982/josam.847350 · Cited by 2
“of visceral adipose tissue correlates with the volume of EFT, and thus, echocardiographic assessment has a crucial role in the cardiovascular risk assessment of patients with MetS and obesity [24].”
BackgroundKashtanova, E. V., Polonskaya, Y. V., Щербакова, Л. В., Stakhneva, E. M., Шрамко, В. С., Mustafina, S. V., Khudyakova, A. D., & Ragino, Y. I. (2024) · Obesity and metabolism · doi:10.14341/omet12974 · Cited by 2
Cardiac Metabolic Implications of Fat Depot Imaging
Hendricks, S., Rassaf, T., & Mahabadi, A. A. (2020) · Current Cardiovascular Imaging Reports · doi:10.1007/s12410-020-9531-3 · Cited by 2
Akinlade, K. S., Ayinde, A. O., Rahamon, S. K., & Sanusi, R. A. (2020) · Diabesity · doi:10.15562/diabesity.2020.65 · Cited by 1
Epicardial Adipose Tissue as a New Target of Therapeutic Interventions
Druzhilov, М. A., & Kuznetsova, Т. Y. (2020) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2020-08-15 · Cited by 2
Eckel, J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809518-8.00005-2 · Cited by 1
Tarabay, A., Hamdy, N., Kady, E. A., & Mostafa, A. (2025) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-025-00437-6 · Cited by 1
A Surgical Model for Graft of Brown Adipose Tissue on the Heart Surface in Mice
Zhou, Z.-A., Fu, Q., Liu, Z., Wang, L., Xu, F., Lin, X., Yuan, L., Zhang, Z., & Liao, X. (2025) · Journal of Visualized Experiments · doi:10.3791/67289 · Cited by 1
Lu, Y., Zhang, R., Yang, J., Liu, D., Wu, Q., Long, X., Cheng, D., Guo, J., Li, Q., Zhang, Y., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-106756 · Cited by 2
Shang, S., Jia, L., & Lin, X. (2026) · Scientific Reports · doi:10.1038/s41598-026-41135-9 · Cited by 1
“Previous studies have demonstrated that CTRP9 exerts multiple vasoprotective effects during the development and progression of atherosclerosis 2,18 .”
Mo, H., Yang, Q., Wang, Y., Yan, Q., Sun, S., Yu, H., Shi, Y., Wang, F., & Cheng, M. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-026-02118-y · Cited by 1
“…integrity due to low cholesterol, diminished stress response, reduced anti-inflammatory and antioxidant capacity due to dysfunctional HDL-C, leading to accelerated vascular endothelial injury, and impaired prostaglandin synthesis and immune function due to essential fatty acid deficiency [15, 16].”
Associations Between Metabolic Dysregulation and Stage B Heart Failure in Hispanic Populations
Lee, M., Patnaik, S., Molina, E., McPherson, D. D., McCormick, J. B., Fisher‐Hoch, S. P., & Laing, S. T. (2026) · Echocardiography · doi:10.1111/echo.70503 · Cited by 1
Role of SGLT2 inhibitors in the treatment of visceral obesity
Druzhilov, М. A., & Kuznetsova, Т. Y. (2021) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2021-2648 · Cited by 1
Obesity and head and neck cancer
Bakar, D., & Mehrzad, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90965-5.00016-7 · Cited by 1
Vasilev, Y. A., Goncharova, I. V., Vladzymyrskii, A. V., Михайлович, Ш. И., & Arzamasov, K. M. (2023) · Science and Innovations in Medicine · doi:10.35693/2500-1388-2023-8-4-271-280 · Cited by 1
Effects of Angiotensin Receptor Blockers on Apelin and Visfatin in Hypertension
Mohammed, M. K., Fathi, Z. H., & Mohammad, J. A. (2024) · Al- Anbar Medical Journal · doi:10.33091/amj.2024.146572.1565
“Neutrophils create PBEF/visfatin in response to endotoxin stimulation, which prevents the apoptosis of neutrophils [69].”
BackgroundEvaluation of Lipid Profile in Patients with Ischemic Heart Disease
Neama, Z. M., & Shwaikh, A. K. (2024) · kerbala journal of pharmaceutical sciences · doi:10.62472/kjps.v14.i23.92-105 · Cited by 1
Golden, A. K. (2020) · Springer eBooks · doi:10.1007/978-3-030-48683-9_5 · Cited by 1
Zhuravlyova, L., Sokolnikova, N. V., & Rogachova, T. (2021) · Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini · doi:10.15407/internalmed2021.02.022 · Cited by 1
Personalized gene-diet study of rs2239670 gene variants and dietary patterns among obese adults
Khodarahmi, M., Niknam, M., & Farhangi, M. A. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.11.010 · Cited by 1
Shahawy, M. E., Izadi, L., Sabatini, A., TUCKER, S. M., Patella, J., Shahawy, O. E., & Yturralde, F. (2020) · medRxiv · doi:10.1101/2020.06.28.20141622 · Cited by 1
“Additionally, other studies found an association between increased accumulations of EFV/EAT and metabolic syndrome.(8,9) EFV/EAT has also been associated with multiple independent cardiac risk factors, such as high fasting glucose, high levels of C-reactive protein, low HDL and carotid intima-media thickness.”
BackgroundGalmes-Panades, A. M., Konieczna, J., Varela-Mato, V., Abete, I., Babió, N., Fiol, M., Fernández, J. A. D. P., Casas, R. M., Olbeyra, R. P., Ruiz‐Canela, M., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-44115/v1 · Cited by 1
HuR brings the heat: linking adipose tissue to cardiac dysfunction
Hall, M. E., & Kipchumba, R. K. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00305.2021 · Cited by 1
Wang, J., su, T., Li, Y., Su, Y., & Li, Y. (2024) · medRxiv · doi:10.1101/2024.09.29.24314577 · Cited by 1
dos Santos, M. A. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.9.2017.tde-20122017-150812
In Need of Signalling Pathway Data
Pizard, A. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1219
de Oliveira, C. E. P. (2018) · doi:10.18002/10612/7958
Sleep, dietary patterns and metabolic health in UK adults
Potter, G. D. (2018) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Molecular Mechanisms and Intervention Strategies in Breast Cancer Associated with Obesity
Luo, G. (2018) · Interventions in Obesity & Diabetes · doi:10.31031/iod.2018.02.000537
“The relationships between obesity and diabetes, and between obesity and heart disease are well accepted [18,19], while the impact of obesity on cancer is still ongoing.”
BackgroundShahawy, M. E., Mohan, S., & Sabatini, A. (2021) · Journal of Integrative Cardiology · doi:10.15761/jic.1000306
“Epicardial adipocytes are also smaller than that of abdominal visceral adipocytes [3,6].”
BackgroundEl, S. M., Schultz Katelyn, J., Mohan, S., Palmer Genevieve, M., Yturralde, F., & Sabatini, A. (2021) · Annals of Heart · doi:10.36959/652/403
710 歴史的町並みにおける修理・修景マニュアルの作成 : 福岡県八女市福島地区街なみ環境整備事業(都市計画)
木村, 寛., & 西山, 徳. (1999) · 日本建築学会九州支部研究報告 3 計画系
Rapún, M.-L., & Sayas, F.-J. (2006) · ESAIM Mathematical Modelling and Numerical Analysis · doi:10.1051/m2an:2006033
Drug-induced metabolic alterations in adipose tissue - with an emphasis in epicardial adipose tissue
Pinho, A. C. O., Burgeiro, A., Pereira, M. J., & Carvalho, E. (2022) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202220201819
Vicente, V., Duarte, A. C. G. D. O., Furino, V. D. O., & Fabrizzi, F. (2022) · Research Society and Development · doi:10.33448/rsd-v11i5.28092
Liaw, F., Pei, D., Chen, Y., Kao, T., Chen, F. Y., & Huang, L.-Y. (2022) · Research Square · doi:10.21203/rs.3.rs-1642405/v1
TÜRK, H. K., Pekgör, S., & Eryılmaz, M. A. (2022) · Family practice and palliative care · doi:10.22391/fppc.1001148
Стаценко, М. Е., Fabritskaya, S. V., Ryndina, Y. A., & Шилина, Н. Н. (2021) · Journal of Volgograd State Medical University · doi:10.19163/1994-9480-2021-4(80)-88-95
Effect of Dapagliflozin on Visceral Fat Index in Overweight Type 2 Diabetes Patients
毕, 佳. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.131064
Сlinic and pathogenic significance of omentin.
Korzh, O., & Fylenko, Y. M. (2023) · Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini · doi:10.15407/internalmed2023.02.095
Issa, E. F., & Rasheed, M. K. (2022) · Iraqi journal of Medical Sciences · doi:10.22578/ijms.20.2.11
Pavlidou, E., Fasoulas, A., Petridis, D., Tryfonos, C., & Giaginis, C. (2023) · Austin Journal of Nutrition and Food sciences · doi:10.26420/austinjnutrifoodsci.2023.1170
Obi-Nwosu, A. L., Nwosu, B. O., Ezemenahi, S. I., Obi-Nwosu, D. I., Nwosu, C., Azudialu, B. C., Ojiakor, C. S., Umeh, U. M., Izuchukwu, E. C. O., Ofiaeli, C. I., et al. (2024) · Nigerian Journal of Clinical Practice · doi:10.4103/njcp.njcp_396_23
Saleem, N., Rafique, S., Muneeb, H. N., Karim, A., Aqdas, A., & Ali, F. S. (2024) · Journal of Health and Rehabilitation Research · doi:10.61919/jhrr.v4i2.885
Relationship of normal weight central obesity on comorbid diseases: Systematic Review
Hanifah, W., & Syarif, S. (2024) · AcTion Aceh Nutrition Journal · doi:10.30867/action.v9i2.1697
“Visceral fat accumulation is closely related to cardiometabolic disorders, DM, dyslipidemia, hypertension, and MS markers (González et al., 2017; Li et al., 2022).”
BackgroundSGLT2 Inhibitors and Mechanism of Cardiovascular Benefits in Type 2 Diabetes
Nandave, M. (2024) · Springer eBooks · doi:10.1007/978-981-97-7568-2_2
Salamy, A. Z. N., Fahmi, G. Z., Rachkutho, T., Fahira, F. T., Rahmanda, A. F., Widodo, N., Dafa, R., Albarok, M. A. R., Fatmaningrum, W., & Widodo, H. S. (2024) · Jurnal Surya · doi:10.38040/js.v16i3.1048
Yang, H., Lam, K., Chou, C.-J., Wen, B.-Y., Wang, C.-B., Lee, Y., Lin, C., & Cheng, P.-Y. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.110005
Elevated Epicardial Adipose Tissue and Ischemic Stroke Risk: A Systematic Review and Meta-Analysis
Mahadevan, A., Pinnamaneni, M., Krishnakumar, M., Mishra, T., Adrejiya, P., Sanjeevi, A., Patel, B. M., Patel, S., Patel, R., Jena, N. K., et al. (2025) · Medicina · doi:10.3390/medicina61122128 · Cited by 1
Galmes-Panades, A. M., Konieczna, J., Varela-Mato, V., Abete, I., Babió, N., Fiol, M., Antonio de Paz, J., Casas, R., Olbeyra, R. P., Ruiz‐Canela, M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13524902
Bai, J., Gao, C., Li, X., Pan, H., Wang, S., Shi, Z., & Zhang, T. (2024) · Figshare · doi:10.6084/m9.figshare.26609667
Galmes-Panades, A. M., Konieczna, J., Varela-Mato, V., Abete, I., Babió, N., Fiol, M., Antonio de Paz, J., Casas, R., Olbeyra, R. P., Ruiz‐Canela, M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13524905
Hu, Y., Zheng, J., Xing, Y., Song, Y., & Wu, X. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s518916
“12 16–18 Additionally, obesity, particularly visceral obesity, places the body in a state of chronic inflammation, which aggravates insulin resistance in patients with T2DM, increases the risk of vascular complications, and elevates the mortality of patients.”
Obesity-Associated Cardiac Fibrosis: Mechanisms and Emerging Therapeutic Targets
Zhou, D., Tan, Y., Zhao, J., Wang, S., Wang, Z., Bai, M., Niu, X., & Zhang, Z. (2026) · Vascular Health and Risk Management · doi:10.2147/vhrm.s567568
“47 The fat tissue around the heart is divided into two layers based on anatomical location: EAT and paracardial adipose tissue (PAT).”
Lipid rewiring by adipose tissue macrophages during diet-induced inflammation and insulin resistance
Dahik, V. D. (2023) · theses.fr (ABES) · doi:10.70675/8f4f001ez6ebez4d7az934bz039a1f4d4116
Rôle du stress oxydant dans le remodelage cardiaque induit par l'obésité
Masri, Y. E. (2024) · theses.fr (ABES) · doi:10.70675/8079719dzd619z4251z9b8fz80e07d39e6c9
Metadata
- Authors
- González, N., Moreno-Villegas, Z., González-Bris, A., Egido, J., & Lorenzo, Ó.
- Affiliations
- Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (ES)
- Hospital Universitario Fundación Jiménez Díaz (ES)
- Corresponding author
- Lorenzo, Ó.
- Venue
- Cardiovascular Diabetology
- Published
- 2017-04-04
- Volume
- 16
- Issue
- 1
- Pages
- 44-44
- ISSN
- 1475-2840 (ISSN-L)
- PMC
- PMC5379721
- OpenAlex
- W2604392184
- Cited by
- 211
- References
- 124
- Citations by year
- 2026: 15 · 2025: 12 · 2024: 28 · 2023: 14 · 2022: 29 · 2021: 30 · 2020: 29 · 2019: 22 · 2018: 24 · 2017: 5
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Cardiovascular Diabetology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Banco de Santander-Universidad Autónoma (CEAL-AL/2015-17)
- Esteve Laboratories (2017)
- ISCarlos III (PI14/00386, PIE13/00051)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- visceral adipose tissue, epicardial adipose tissue, obesity, type 2 diabetes, cardiovascular disease, diabetic cardiomyopathy, adipocyte phenotype, brown adipocytes, adipokines, PPARγ agonists, statins, incretin-based therapy, insulin resistance, heart failure, body fat distribution
- MeSH terms
- Adipose Tissue, Adipose Tissue, Brown, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Obesity, Pericardium, Intra-Abdominal Fat, Incretins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
